Skip to main content
Image
Committee Activity Banner Image

Hearing on "Legislative Proposals to Prevent and Respond to Generic Drug Shortages"

Date:
Location:
John D. Dingell Hearing Room, 2123 Rayburn House Office Building

The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Thursday, September 14, 2023, at 10 a.m. in the John D. Dingell Hearing Room, 2123 Rayburn House Office Building. The hearing is entitled, "Legislative Proposals to Prevent and Respond to Generic Drug Shortages."

 

Key Documents

Opening Statement from Ranking Member Pallone as prepared for delivery

Opening Statement from Subcommittee Ranking Member Eshoo as prepared for delivery

 

Livestream

 

Legislation

H.R. ___, the Stop Drug Shortages Act

H.R. 3008, the Drug Shortage Prevention Act of 2023

H.R. 3810, the Drug Origin Transparency Act of 2023 

H.R. 3793, the Ensuring Access to Lifesaving Drugs Act of 2023 

H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023  

 

Witnesses

Dr. Michael Ganio
Senior Director, Pharmacy Practice and Quality
American Society of Health System Pharmacists (ASHP)
 
 
 
Chester “Chip” Davis, Jr., JD
President and Chief Executive Officer
Healthcare Distribution Alliance (HDA)
 
 
 
Dr. Melissa Barber
Postdoctoral fellow
Yale School of Medicine, Yale Law School, and Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
 
 
 
Allan Coukell, BScPharm
Senior Vice President, Public Policy
Civica
 
 
 
David Gaugh, R.Ph.
Interim President and CEO
Association for Accessible Medicines (AAM)
 
 
 
Todd Ebert, R.Ph.
President and CEO
Healthcare Supply Chain Association (HSCA)
 
 
 
 
Issues:Health